Harold Bernstein, President, R&D & CMO: Maze Therapeutics MAZE Sell · Filed 05/18

Trade details

Type: Insider sale
Amount: $393,300
Shares · price: 15,000 sh · $26.22 a share
Held after: 0 sh
Stock: Maze Therapeutics MAZE
Person: Harold BernsteinPresident, R&D & CMO
Trade date: 26/05/14
Filed: 26/05/18
Days to filing: 4 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 04/14~06/13

Harold Bernstein's recent trades

Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$251.1K
9,705 sh
$251.1K
Filed 09/04
Traded 09/04
Harold BernsteinPresident, R&D & CMO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$283.5K
10,685 sh
$283.5K
Filed 09/02
Traded 09/02
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1.4M
46,892 sh
$1.4M
Filed 07/01
Traded 07/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$338.9K
13,253 sh
$338.9K
Filed 06/03
Traded 06/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$42.2K
1,600 sh
$42.2K
Filed 06/03
Traded 06/01

Harold Bernstein, CMO — sold $393.3K of Maze Therapeutics MAZE · 100.0% of holdings · 10b5-1 plan | Whalegun